Ali Erginay · enciclopedia

Publicaciones › Cribado, telemedicina (OPHDIAT) y epidemiología de la retinopatía diabética

Hemoglobin A1c and Fasting Plasma Glucose Levels as Predictors of Retinopathy at 10 Years: The French DESIR Study

Hemoglobina A1c y niveles de glucosa en plasma en ayunas como predictores de retinopatía a 10 años: El estudio francés DESIR

Año2011
FuenteArchives of ophthalmology (Chicago, Ill. : 1960)
Tipoarticle · Journal Article, Research Support, Non-U.S. Gov't
Autores (9)Pascale Massin, Céline Lange, Jean Tichet, Sylviane Vol, Ali Erginay, Martine Cailleau, Eveline Eschwège, Beverley Balkau, DESIR (Data From an Epidemiological Study on the Insulin Resistance Syndrome) Study Group
Posición de Erginay5 de 9
Citas60 (OpenAlex)
EnlacesDOI 10.1001/archophthalmol.2010.353 · PubMed 21320965 · OpenAlex · Texto completo en acceso abierto
LíneasCribado, telemedicina (OPHDIAT) y epidemiología de la retinopatía diabética Enfermedades vasculares, genéticas e inflamatorias de la retina Retinopatía diabética: clínica, función y progresión

En pocas palabras

Se estudió la relación entre los niveles de hemoglobina A1c y glucosa en plasma en ayunas con el desarrollo de retinopatía en un período de 10 años. Los resultados mostraron que los participantes con retinopatía tenían niveles más altos de glucosa y hemoglobina A1c al inicio del estudio. Se encontró que umbrales específicos de glucosa y hemoglobina A1c pueden identificar a las personas en riesgo de desarrollar retinopatía

Resumen divulgativo generado automáticamente a partir del resumen original; puede contener imprecisiones.

Resumen original

OBJECTIVE: To evaluate the predictive values of hemoglobin A(1c) (HbA(1c)) and fasting plasma glucose (FPG) for retinopathy 10 years after the baseline examination. METHODS: Seven hundred men and women from the DESIR (Data From an Epidemiological Study on the Insulin Resistance Syndrome) Study underwent evaluation for retinopathy using a nonmydriatic digital camera. During the preceding 9 years, 235 had diabetes mellitus (treated or FPG level of ≥126 mg/dL at least once), 227 had an impaired FPG level (110-125 mg/dL) at least once, and 238 always had glucose levels within reference limits (<110 mg/dL). RESULTS: Compared with those without retinopathy, the 44 participants with retinopathy at 10 years had higher baseline mean (SD) levels of FPG (130 [49] vs 106 [22] mg/dL) and HbA(1c) (6.4% [1.6%] vs 5.7% [0.7%]) (both, P < .001). The frequency of retinopathy at 10 years, standardized according to the distribution of glycemia across the entire DESIR population, was 3.6%. In our population, FPG levels of 108 and 116 mg/dL had positive predictive values of 8.4% and 14.0%, respectively, for retinopathy at 10 years; HbA(1c) levels of 6.0% and 6.5% had positive predictive values of 6.0% and 14.8%, respectively. After 10 years of follow-up, retinopathy was equally frequent in participants with impaired FPG levels and in those who became diabetic during the study (8.6% and 6.7%, respectively), lower than in those with diabetes at baseline (13.9%). CONCLUSION: Because the positive predictive values for retinopathy increase sharply from 108 mg/dL for FPG and from 6.0% for HbA(1c) levels, these thresholds are proposed to identify those at risk of retinopathy 10 years later.

Términos MeSH

Adult Aged Blood Glucose Blood Pressure Diabetic Retinopathy False Positive Reactions Fasting Female Follow-Up Studies Glycated Hemoglobin Humans Male Middle Aged Prediabetic State Predictive Value of Tests Risk Factors Surveys and Questionnaires